359801-19-7 Usage
Uses
Due to the limited information available on 4-(4-benzylpiperazin-1-ylmethyl)benzoic acid, the following potential applications are speculative and based on the general properties of similar benzene derivatives:
Used in Pharmaceutical Industry:
4-(4-Benzylpiperazin-1-ylmethyl)benzoic acid could be used as an active pharmaceutical ingredient for the development of new drugs, given its potential reactivity and chemical characteristics that may allow it to interact with biological targets.
Used in Chemical Research:
In the field of chemical research, 4-(4-benzylpiperazin-1-ylmethyl)benzoic acid may serve as a starting material or intermediate in the synthesis of more complex organic molecules, contributing to the advancement of organic chemistry.
Used in Material Science:
Given its aromatic nature, 4-(4-benzylpiperazin-1-ylmethyl)benzoic acid might be utilized in the development of new materials with specific properties, such as in polymers or as part of a composite material, depending on its stability and reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 359801-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,8,0 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 359801-19:
(8*3)+(7*5)+(6*9)+(5*8)+(4*0)+(3*1)+(2*1)+(1*9)=167
167 % 10 = 7
So 359801-19-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H22N2O2/c22-19(23)18-8-6-17(7-9-18)15-21-12-10-20(11-13-21)14-16-4-2-1-3-5-16/h1-9H,10-15H2,(H,22,23)
359801-19-7Relevant academic research and scientific papers
Ou, Yu,Luo, Min,Dong, Yong-Xi,Su, Hang,Fu, Xiao-Zhong,Cha, Yu-Feng,Zhang, Shun,Zhao, Yong-Long,Li, Yong-Jun,Wang, Yong-Lin
, p. 2205 - 2213 (2016)
A series of 4′-N-substituted (aminomethyl) benzoate-7-substituted nicotinic acid ester derivatives of scutellarein was designed and synthesized. Evaluation of physiochemical properties showed that the newly designed compounds had greater chemical stability and aqueous solubility than scutellarin or scutellarein. The permeabilities (Papp AP to BL) of compounds 7b and 7e in Caco-2 cells were 5.9-fold and 3.7-fold higher than that of scutellarin, and 3.7-fold and 2.4-fold higher than that of scutellarein. The permeabilities (Papp AP to BL) of compounds 7b and 7e in an in vitro model of the blood–brain barrier were 9.7-fold and 5.9-fold higher than that of scutellarin, and 9.2-fold and 5.6-fold higher than that of scutellarein.
